^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
MHB036C
i
Other names: MHB036C, ZG157
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Minghui Pharma
Drug class:
Topoisomerase I inhibitor, TROP-2-targeted antibody-drug conjugate
Related drugs:
2years
Study of MHB036C in Participants With Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
P1/2, N=400, Not yet recruiting, Minghui Pharmaceutical Pty Ltd
New P1/2 trial • Metastases
|
TACSTD2 (Tumor Associated Calcium Signal Transducer 2)
|
HER-2 positive • HR positive • HER-2 expression • TROP2 expression • PGR expression
|
MHB036C
Share via
